TELOSAF MT 40/25 TABLET

Product Description

Product Name: TELOSAF MT 40/25 TABLETComposition: Telmisartan 40 mg + Metoprolol Succinate 25 mg (Sustained Release)Product Description (SEO-Optimized for Trade India & B2B Platforms)TELOSAF MT 40/25 TABLET is a clinically advanced antihypertensive combination, formulated with Telmisartan 40 mg (an angiotensin II receptor blocker) and Metoprolol Succinate 25 mg (a beta-blocker in sustained-release form). This dual-action therapy ensures comprehensive blood pressure control, reducing both systolic and diastolic pressure while offering cardioprotective benefits.Manufactured by Agrosaf Pharmaceuticals in WHO-GMP certified facilities, this formulation is ideal for bulk purchasing, PCD pharma franchise, hospital tenders, and pharmacy distributors looking for reliable, high-demand cardiovascular medicines.Key Benefits: Combines ARB and beta-blocker for synergistic hypertension management Sustained-release Metoprolol ensures steady, 24-hour action Helps prevent stroke, heart failure, and cardiovascular complications Convenient once-daily dosage promotes better patient adherence Usage: Indicated for the treatment of essential hypertension and cardiovascular risk reduction, particularly in patients requiring combination therapy. Available for Bulk Orders, PCD Franchise & Contract Manufacturing. Trust TELOSAF MT 40/25 TABLET for clinically effective and market-ready hypertension care.TELOSAF MT Dual Power, Reliable Control.